JT
BEAM icon

Jupiter Topco’s Beam Therapeutics BEAM Stock Holding History

Jupiter Topco’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.26M Buy
+94,969
New +$2.87M ﹤0.01% 1244

Other funds holding BEAM

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jupiter Topco's BEAM Position: Q2 2026 in Review

Jupiter Topco opened a new position in Beam Therapeutics (BEAM) in Q2 2026: 94,969 shares worth $3.26M. The stake represents ﹤0.01% of the portfolio and ranks #1244 among its holdings.

255 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Jupiter Topco held 94,969 shares of Beam Therapeutics worth $3.26M as of Q2 2026.
  • Beam Therapeutics was a new Jupiter Topco position in Q2 2026.
  • Beam Therapeutics made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #1244 holding.
  • 255 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.